Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
Authors:
- 1 October 1995
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 1 (10) , 1029-1034
Abstract
The complete coding region of the p53 gene was sequenced from 316 consecutively presented breast cancers, of which 97 were lymph node positive and 206 were node negative. The p53 status was related to prognosis and effect of adjuvant therapy. In all, 69 individual mutations, 29 in node–positive tumours, were demonstrated throughout the whole coding sequence. The mutation sites were partly different for node–positive and node–negative patients. p53 mutations in the evolutionary conserved regions II and V were associated with significantly worse prognosis. Adjuvant systemic therapy, especially with tamoxifen, along with radiotherapy seemed to be of less value to p53 mutation– and lymph node–positive tumours.Keywords
This publication has 19 references indexed in Scilit:
- Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: Five-Year Results of a Randomized TrialJNCI: Journal of the National Cancer Institute, 1994
- The Importance of p53 Gene Alterations in Human Cancer: Is There More Than Circumstantial Evidence?JNCI: Journal of the National Cancer Institute, 1993
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- p53 function and dysfunctionCell, 1992
- p53, guardian of the genomeNature, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI: Journal of the National Cancer Institute, 1992
- The p53 tumour suppressor geneNature, 1991
- Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitroInternational Journal of Cancer, 1990
- P53 expression in breast cancerInternational Journal of Cancer, 1988
- Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expressionEuropean Journal of Biochemistry, 1986